GlaxoSmithKline (GSK) aims to have its respiratory syncytial virus (RSV) vaccine reviewed later this year; Northwell Health and Kaiser Permanente among CEOs supporting gun legislation; Infants whose mothers had COVID-19 during their pregnancy had double the risk of delayed speech or motor skills.
Read More
Mazyar Shadman, MD, MPH, of Fred Hutchinson Cancer Research Center and University of Washington, discussed positive health-related quality of life (HRQOL) findings of the SEQUOIA trial investigating zanubrutinib vs bendamustine/rituximab in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Watch
Genetics, Immunophenotyping Help Drive CLL Treatment Selection, but More Knowledge Needed
June 10th 2022An education session at the 2022 European Hematology Association Congress featured updates on using genetic and immune characteristics to select the optimal treatment pathway in chronic lymphocytic leukemia (CLL).
Read More
Combining Techniques Boosts Diagnostic Sensitivity in Intrahepatic Cholangiocarcinoma
June 9th 2022Hepatobiliary-phase enhanced imaging outperformed diffusion-weighted imaging in distinguishing intrahepatic mass-forming cholangiocarcinoma, but the accuracy is greater when these methods are used in tandem.
Read More
Vaping Injuries Associated With Long-term Respiratory Problems, Study Finds
June 9th 2022A new study found that patients with e-cigarette or vaping–associated lung injury had a higher risk of developing respiratory disability, cognitive impairment, symptoms of depression, anxiety, and posttraumatic stress within 1 year of their injury.
Read More
Health Care Access, Preventive Care Similar in MA and TM for Low-Income Adults
June 9th 2022The analysis of adults with low income enrolled in Medicare Advantage (MA) or traditional Medicare (TM) indicates that increasing enrollment in MA may not advance health equity in the Medicare program.
Read More
An experimental cancer drug made 100% of patients’ rectal tumors disappear in a small study; US military members with HIV with an undetectable viral load and no symptoms will no longer face restrictions in deployment or commission; President Biden may sign an executive order on abortion rights depending on the Supreme Court’s ruling.
Read More
FDA Widens Use of Dupilumab to Children With AD as Young as 6 Months
June 9th 2022The FDA this week expanded the use of dupilumab for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis (AD) whose disease is not controlled with topical prescription therapies or when those treatments can't be used.
Read More
CREATE Trial Data Add to Support of Open-Source AID Use in T1D
June 9th 2022Findings presented at the 82nd Scientific Sessions of the American Diabetes Association support the safety and efficacy of open-source automated insulin delivery (AID) systems among children and adults living with type 1 diabetes (T1D).
Read More
Ashok Subramanian on Considerations for Employers Designing Value-Based Care Frameworks
June 8th 2022Ashok Subramanian, MBA, founder and chief executive officer, Centivo, speaks on the limitations of traditional employer-based health benefit plans in the pursuit of value-based care and what employers should consider in designing these incentives on a community level.
Watch
Dupilumab Efficacy in Asthma, AD, EoE, and CRSwNP Not Affected By Eosinophil Count
June 8th 2022Dupilumab-induced increases in mean eosinophil counts were shown to wane over time in patients with asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and atopic dermatitis (AD), with incidence of eosinophilia not shown to reduce efficacy of the biologic.
Read More
Dr Michael Thorpy Explains Findings From REST-ON Trial for Narcolepsy Treatment
June 8th 2022Once-nightly sodium oxybate was associated with a statistically significant reduction in cataplexy episodes among patients with narcolepsy, explained Michael Thorpy, MD, director of the Sleep-Wake Disorders Center at Montefiore Medical Center and professor of neurology at Albert Einstein College of Medicine.
Watch
The Challenges of Living With Narcolepsy While Pregnant and How Providers Can Help
June 8th 2022A panel of providers and patients with narcolepsy who are parents shared the struggles and possible support tools that neurologists and other providers should be aware of when caring for patients with narcolepsy who are pregnant or postpartum.
Read More
Idiopathic Hypersomnia Needs More Attention to Overcome Challenges Regarding Diagnosis and Treatment
June 8th 2022During her presentation at SLEEP 2022, Isabelle Arnulf, MD, PhD, a neurologist and professor, detailed the long list of challenges for understanding different aspects of idiopathic hypersomnia and called for more attention to be devoted to future research.
Read More
What We're Reading: FTC Launches PBM Inquiry; FDA Advisers Recommend Novavax; Drug Prices Soar
June 8th 2022The Federal Trade Commission (FTC) launched an inquiry into the practices of pharmacy benefit managers; FDA advisers overwhelmingly support approval of Novavax, a new COVID-19 vaccine; drug prices soar to 20% annual inflation.
Read More
EHA2022 to Offer Array of Research on Cancer Treatments, Blood Disorders
June 8th 2022The 2022 European Hematology Association (EHA) Congress will be the group’s first hybrid meeting, in which investigators will convene both virtually and in Vienna, Austria, from June 9-12, 2022, to present cutting-edge findings in the realm of oncology and hematology.
Read More
Dr Sean Drummond Discusses Pros, Cons of Consumer Sleep Technology
June 8th 2022While consumer wearables for sleep are popular, evidence-based guidelines need to be established to interpret data coming from these technologies, said Sean Drummond, PhD, professor of clinical neuroscience, Turner Institute for Brain and Mental Health at Monash University.
Watch